Access platform-led growth prospects ahead
12 September 2023Investor Centre

Access platform-led growth prospects ahead
12 September 2023Early onset of synergies from Access acquisition
30 August 2023Raise anticipated to fund the Access acquisition
14 August 2023wheezo to access a larger addressable market
17 July 2023Investor recap of Respiri’s strategic focus
7 June 2023Telehealth acquisition to bolster US roll-out
23 May 2023Access acquisition delivers new RPM and RTM opportunities
1 September 2023Acquiring US remote patient monitoring partner ACCESS
24 May 2023Adding primary care specialty practice in New Mexico for wheezo® RPM offering
16 December 2022Minnesota Lung Center wheezo® pilot up and running with first patients enrolled
15 December 2022First primary care specialty practice for wheezo®/Access RPM program
9 December 2022wheezo® adoption momentum grows
29 November 2022Want to find out more information about Vitasora? We would love to hear from you.
Enquire now